Knowledge Hub

Deep dives for pharma professionals

Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.

141 articles in the hub
GVP Module VI: An OverviewResearch

GVP Module VI: An Overview

A clear overview of GVP Module VI, explaining ICSR requirements, timelines, and EudraVigilance reporting in the EU.

Vaibhavi M.Jan 20, 2026
GVP As A Growth Strategy: Turning Safety Data Into Competitive AdvantageResearch

GVP As A Growth Strategy: Turning Safety Data Into Competitive Advantage

How Good Pharmacovigilance Practices are evolving from compliance into a strategic growth and trust-building function in pharma.

Vaibhavi M.Jan 20, 2026
Advantages and Limitations of Non-Viral Delivery SystemsResearch

Advantages and Limitations of Non-Viral Delivery Systems

A strategic look at non-viral drug delivery systems, their advantages, limitations, and growing role in RNA, gene, and precision therapies.

Mrudula KulkarniJan 19, 2026
How 2025 Changed Pharma: The Mergers & Acquisitions That Truly MatteredMarket Trends

How 2025 Changed Pharma: The Mergers & Acquisitions That Truly Mattered

A deep dive into the biggest pharma mergers of 2025 and how targeted acquisitions reshaped pipelines, innovation strategy, and long-term growth.

Ravindra WarangJan 1, 2026
From Human Inspection To Machine Vision: The Future Of AI-Powered Contamination Detection In PharmaResearch

From Human Inspection To Machine Vision: The Future Of AI-Powered Contamination Detection In Pharma

AI vision systems are reshaping pharma quality control by detecting contamination faster, improving consistency, and strengthening compliance.

Simantini Singh DeoDec 24, 2025
Next-Gen CAR-T Cells: Overcoming Tumor Microenvironment ChallengesInnovation

Next-Gen CAR-T Cells: Overcoming Tumor Microenvironment Challenges

Next-gen CAR-T cells are designed to overcome the tumor microenvironment and finally make solid tumor immunotherapy possible.

Mrudula KulkarniDec 22, 2025
The Antibiotic Resistance: Zosurabalpin And The War On SuperbugsResearch

The Antibiotic Resistance: Zosurabalpin And The War On Superbugs

Zosurabalpin is a first-in-class antibiotic targeting Gram-negative superbugs and offering new hope against antimicrobial resistance.

Vaibhavi M.Dec 22, 2025
Alzheimer’s Breakthrough Pipelines In The Pharmaceutical IndustryResearch

Alzheimer’s Breakthrough Pipelines In The Pharmaceutical Industry

Alzheimer’s drug pipelines are evolving as amyloid antibodies, oral agents, and precision trials redefine disease-modifying strategies.

Vaibhavi M.Dec 22, 2025
Non-Viral Delivery Systems: The Quiet Powerhouses Redefining Modern TherapeuticInnovation

Non-Viral Delivery Systems: The Quiet Powerhouses Redefining Modern Therapeutic

Non-viral delivery systems enable safer, scalable gene therapy and mRNA delivery, reshaping advanced therapeutics beyond viral vectors.

Mrudula KulkarniDec 19, 2025
Raman + Hyperspectral Imaging In QC In The Pharmaceutical IndustryInnovation

Raman + Hyperspectral Imaging In QC In The Pharmaceutical Industry

Raman spectroscopy and hyperspectral imaging enable faster, non-destructive pharmaceutical QC with deep chemical insight and spatial accuracy.

Vaibhavi M.Dec 18, 2025
How to Build a Contamination Control Strategy (CCS) That WorksResearch

How to Build a Contamination Control Strategy (CCS) That Works

Explore how CCS strengthens sterility, reduces deviations, and drives proactive contamination control in pharma.

Mrudula KulkarniDec 1, 2025
Beyond One-Size-Fits-All: How Flow Chemistry And Targeted Delivery Are Shaping Personalized MedicineResearch

Beyond One-Size-Fits-All: How Flow Chemistry And Targeted Delivery Are Shaping Personalized Medicine

Flow chemistry and smart delivery systems are redefining drug design, precision dosing, and personalized medicine.

Simantini Singh DeoDec 1, 2025